Dr. Kurt Allan Melstrom Jr., MD

Dr. Melstrom practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Melstrom's NPI, 1508026832, was assigned on June 10, 2008. Dr. Melstrom graduated from Weill Cornell Medicine in 2003. Dr. Melstrom holds California license A135013.

Dr. Melstrom's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Melstrom's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. Dr. Melstrom is also affiliated with Emanate Health Foothill Presbyterian Hospital. The medical group on file is City of Hope. Dmand AI also links Dr. Melstrom to 2 more group practices and clinics, 2 home health agencies, 1 other site and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Melstrom practices, 6 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Melstrom's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Melstrom is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Melstrom's licenses on file in 4 states: California, North Carolina, New York and Illinois.

Dmand AI lists colonoscopy, colon removal and hemorrhoids among the conditions Dr. Melstrom treats.

CMS data shows 379 Medicare services from Dr. Melstrom across 7 procedure codes in 2024, for 245 Medicare patients. Medicare paid $27,767 for them.

CMS counts 245 Medicare patients who saw Dr. Melstrom in 2024. The largest group is 65 to 74, with 115 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Melstrom's median patient age at 66, with 50% women.

In 2024, Dr. Melstrom wrote 206 Medicare Part D claims for 94 patients. 98% of them were for generic drugs. CMS names the drug for 145 of them, across 5 drugs with 11 or more claims each, at $705 in total drug cost. In 2023, CMS named 112 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Melstrom for performance year 2024, reported as part of a group. Dr. Melstrom accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Melstrom as offering telehealth. CMS counts 54 procedures of colonoscopy by Dr. Melstrom, more than 65% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 32 papers to Dr. Melstrom, published from 2017 to 2024. 2024 was the busiest year, with 4. The most frequent topics are Adenocarcinoma, Colectomy and Colorectal Neoplasms. Dr. Melstrom has published most often in J Surg Oncol. Dr. Melstrom's most frequent co-authors are Yuman Fong, MD, Lily Lai, MD and Laleh Golkar Melstrom, MD.

CMS Open Payments shows 36 general payments to Dr. Melstrom from 13 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 44% of the total. Intuitive Surgical, Inc. paid the most, $3,537.

Dmand AI lists 2 awards for Dr. Melstrom, most recently CMS Stage 1 EHR in 2013.

Dr. Melstrom graduated from Weill Cornell Medicine in 2003. Dr. Melstrom is a member of ACS and ASCRS.

Dr. Melstrom is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.